Clinical Trial Update: A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Kadcyla (trastuzumab emtansine) plus capecitabine in HER2-positive metastatic breast cancer or HER2-positive locally advanced/metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Kadcyla (ado-trastuzumab emtansine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer, Gastric Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-04-08